Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: A cross-sectional study

Sexually Transmitted Infections

Volumn 90, Issue 8, 2014, Pages 580-587

  Masson, Lindi ^a,b   Mlisana, Koleka ^b,c   Little, Francesca ^d   Werner, Lise ^b   Mkhize, Nonhlanhla N ^a,e   Ronacher, Katharina ^f   Gamieldien, Hoyam ^a   Williamson, Carolyn ^a,b   McKinnon, Lyle R ^b   Walzl, Gerhard ^f   Karim, Quarraisha Abdool ^b,g   Karim, Salim S Abdool ^b,g   Passmore, Jo Ann S ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; ARTICLE; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDY; FACTORIAL ANALYSIS; FEMALE; GENITAL SYSTEM; GENITAL TRACT INFECTION; GONORRHEA; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LAVAGE; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PLASMA; PREVALENCE; SCREENING; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UPREGULATION; VAGINITIS; VIRUS REACTIVATION; ADOLESCENT; BLOOD; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; VAGINA; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HERPESVIRUS 2, HUMAN; HUMANS; MIDDLE AGED; NEISSERIA GONORRHOEAE; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINALIS; VAGINA; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84911409001     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2014-051601     Document Type: Article

References (30)

1. United Nations Programme on HIV/AIDS report on the global AIDS epidemic, 2010. http://www.unaids.org (accessed 7 Jan 2014).
2. Johnson LF, Dorrington RE, Bradshaw D, et al. The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Healthcare 2011;2:13-20.
3. Quayle AJ. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol 2002;57:61-79.
4. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol 1999;2:99-105.
5. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-74.
6. Fichorova RN, Jasvantrai Desai P, Gibson FC, et al. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 2001;69:5840-8.
7. Yudin MH, Landers DV, Meyn L, et al. Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003;102:527-34.
8. Reddy BS, Rastogi S, Das B, et al. Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women-implication for T-cell responses. Clin Exp Immunol 2004;137:552-8.
9. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007;21:589-98.
10. McGee ZA, Jensen RL, Clemens CM, et al. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-[alpha] concentration to sloughing of ciliated cells. Sex Transm Dis 1999;26:160-5.
11. Parks KS, Dixon PB, Richey CM, et al. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997;24:229-35.
12. Golden MR, Schillinger JA, Markowitz L, et al. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27:329-37.
13. Moodley P, Sturm AW. Sexually transmitted infections, adverse pregnancy outcome and neonatal infection. Semin Neonatology 2000;5:255-69.
14. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6.
15. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-911.
16. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, et al. High levels of tumor necrosis factor-a and interleukin-1ß in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis 2000;182:467-73.
17. Ryckman KK, Williams SM, Krohn MA, et al. Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J Reprod Immunol 2008;78:166-71.
18. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
19. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-706.
20. Mlisana K, Naicker N, Werner L, et al. Vaginal discharge is a poor predictor of sexually transmitted infections and subclinical genital tract inflammation in women at high-risk of HIV infection. J Infect Dis 2012;206:6-14.
21. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009;458:1034-8.
22. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor-alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci 1989;86:2336-240.
23. Wira CR, Fahey JV, Sentman CL, et al. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005;206:306-35.
24. Nazli A, Chan O, Dobson-Belaire WN, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Path 2010;6:e1000852.
25. Bebell LM, Passmore JS, Williamson C, et al. Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J Infect Dis 2008;198:710-14.
26. Columb MO, Sagadai S. Multiple comparisons. Curr Anaesth Crit Care 2006;17:233-6.
27. Costello AB, Osborne JW. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval 2005;10:1531-7714.
28. Hedge SR, Barrientes F, Desmond RA, et al. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006;193:556-62.
29. Mitchell CM, Balkus J, Agnew KJ, et al. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. AIDS Res Hum Retroviruses 2008;24:667-71.
30. Danielsson D, Teigen PK, Moi H. The genital econiche: focus on microbiota and bacterial vaginosis. Ann NY Acad Sci 2011;1230:48-58.